✅ Перевірена відповідь на це питання доступна нижче. Наші рішення, перевірені спільнотою, допомагають краще зрозуміти матеріал.
Researchers are developing a CRISPR–Cas9 therapy to correct a pathogenic point mutation in a gene responsible for an inherited blood disorder. During preclinical testing, several unintended genomic regions are also cleaved, raising concerns about off-target effects. The research team decides to redesign part of the CRISPR system to improve targeting precision.
Which component of the CRISPR–Cas9 system would most directly need to be modified to improve DNA targeting specificity, and why?